To include your compound in the COVID-19 Resource Center, submit it here.

Fluidigm, DVS Sciences deal

Microfluidics company Fluidigm is acquiring DVS Sciences for about $207.5 million in a cash and stock

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE